The Inceptiv data give Medtronic more evidence as it tries to increase sales of a product that drove double-digit growth at ...

Medtronic (NYSE: MDT) today announced 12-month data demonstrating the benefits of its Inceptiv closed-loop spinal cord stimulator (CL-SCS).

Kevin Hill, 65, used to suffer sleepless nights due to his harrowing Parkinson's disease symptoms. Now, he forgets about his ...

Multiple FDA-approved SCS systems, such as Nevro’s Senza and HFX iQ, as well as Medtronic’s Vanta, Intellis, and Inceptiv systems are available, each offering different features to cater to individual ...

Notable achievements include Vietnam's first successful treatment of an epilepsy patient using Deep Brain Stimulation and the ... improving surgical outcomes in spine, hernia, thoracic and ...

“Case outcomes (settlement, plaintiff or defendant ruling) did not statistically vary based on the SCS (spinal cord stimulator) manufacturer type-St. Jude, Boston Scientific Corp., or Medtronic.

Growth stocks have recently attracted investor interest. The Russell 3000 Growth Index returned 39.8% over the last year through Jan. 6. That was more than 24 percentage points better than the ...

Medtronic plc’s MDT strength in the Cardiovascular ... the company is gaining new implant shares in both pain Stim and Deep Brain Stimulation. In pain stim, the market is gaining from the ...

The market is highly competitive, with global players like Medtronic, Johnson & Johnson ... Impact of Bone Morphogenetic Proteins (BMPs) in Spinal Fusion and Bone Regeneration Bone morphogenetic ...